Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • West, Howard; McCleod, Michael; Hussein, Maen; Morabito, Alessandro; Rittmeyer, Achim; Conter, Henry J.; Kopp, Hans-Georg; Daniel, Davey; McCune, Steven; Mekhail, Tarek; Zer, Alona; Reinmuth, Niels; Sadiq, Ahad; Sandler, Alan; Lin, Wei; Lohmann, Tania Ochi; Archer, Venice; Wang, Lijia; Kowanetz, Marcin; Cappuzzo, Federico

Publication Date

  • July 1, 2019

webpage

published in

category

start page

  • 924

end page

  • 937

volume

  • 20

issue

  • 7